ACTIVE

IMMUNODIAGNOSTIC SYSTEMS

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

577,4 k €

+30.0% YoY

Revenue

12,8 M €

+10.6% YoY

Equity

7,4 M €

+8.5% YoY

Workforce

68,9 ETP

+4.1% YoY

What does IMMUNODIAGNOSTIC SYSTEMS do?

IMMUNODIAGNOSTIC SYSTEMS is a Public limited company incorporated in 1989. Its registered office is in Liège. It employs on average 68,9 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0436.921.949

Incorporation

16/02/1989

Legal form

Public limited company

Registered office

Rue Ernest-Solvay 101
4000 Liège · WallonieSee on map

Contributed capital

4 497 677,39 €

Latest accounts

31/12/2025

Average workforce

68,9 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2021		2019		2018		2017		2016		2015		2014		2013		2012		2011		2009		2008
Income statement
Revenue	12,8 M €	+10.6%	11,6 M €	+23.1%	9,4 M €	+10.1%	8,6 M €	+46.5%	5,8 M €	-19.3%	7,2 M €	-6.1%	7,7 M €	-4.6%	8,1 M €	+3.0%	7,8 M €	-10.1%	8,7 M €	+11.8%	7,8 M €	-7.3%	8,4 M €	+10.2%	7,6 M €	-0.1%	7,6 M €	-18.0%	9,3 M €	+207%	3 M €	+3.4%	2,9 M €
EBITDA	920,6 k €	+2097%	41,9 k €	-96.5%	1,2 M €	+128%	519,3 k €	+64.2%	316,2 k €	-53.5%	679,9 k €	+205%	-648,4 k €	-129%	2,2 M €	+96.7%	1,1 M €	+17.5%	961,9 k €	+0.3%	959,3 k €	-36.6%	1,5 M €	+74.4%	867,8 k €	+364%	-329,3 k €	-112%	2,7 M €	+3601%	-76,3 k €	+47.5%	-145,4 k €
Operating result	729,4 k €	+31.2%	556 k €	+24.4%	446,8 k €	+125%	198,8 k €	-15.1%	234,2 k €	+74.7%	134,1 k €	-71.9%	477,1 k €	-3.2%	493 k €	+179%	176,8 k €	-61.6%	460 k €	+22.0%	376,9 k €	-62.3%	1 M €	+244%	290,7 k €	+129%	-1 M €	-158%	1,7 M €	+297%	-871,5 k €	+35.3%	-1,3 M €
Net result	577,4 k €	+30.0%	444 k €	+38.6%	320,4 k €	+226%	98,3 k €	-25.3%	131,6 k €	+322%	-59,3 k €	-106%	924,4 k €	+33.7%	691,3 k €	+68.0%	411,3 k €	-55.6%	926 k €	+51.8%	609,9 k €	-51.4%	1,3 M €	+129%	548,4 k €	+187%	-629,8 k €	-131%	2 M €	+563%	-436,1 k €	+22.8%	-564,7 k €
Balance sheet
Equity	7,4 M €	+8.5%	6,8 M €	+7.0%	6,4 M €	+5.3%	6 M €	+1.6%	5,9 M €	+2.2%	5,8 M €	-52.3%	12,2 M €	-33.3%	18,3 M €	+3.9%	17,6 M €	+2.1%	17,2 M €	+6.5%	16,2 M €	+3.8%	15,6 M €	+8.7%	14,3 M €	+3.9%	13,8 M €	-4.5%	14,4 M €	+38.9%	10,4 M €	-6.9%	11,2 M €
Total assets	10,7 M €	+10.7%	9,7 M €	+8.5%	8,9 M €	-1.2%	9 M €	+26.3%	7,1 M €	+0.8%	7,1 M €	-64.8%	20,1 M €	+2.6%	19,6 M €	+2.9%	19 M €	+4.1%	18,3 M €	+2.5%	17,8 M €	+4.6%	17 M €	+6.9%	15,9 M €	+7.3%	14,9 M €	-18.0%	18,1 M €	+8.6%	16,7 M €	+4.9%	15,9 M €
Cash	474,6 k €	+29.7%	365,8 k €	+52.4%	240,1 k €	-50.3%	482,6 k €	+21.2%	398,1 k €	-46.3%	741,8 k €	+50.6%	492,6 k €	+27.3%	387 k €	+39.2%	278 k €	-7.1%	299,2 k €	+51.0%	198,1 k €	-31.4%	288,6 k €	-21.1%	366 k €	+157%	142,4 k €	-47.6%	272 k €	+246%	78,7 k €	-52.7%	166,4 k €
Debts	3,3 M €	+15.9%	2,9 M €	+12.2%	2,5 M €	-14.3%	3 M €	+149%	1,2 M €	-3.9%	1,2 M €	-84.2%	7,9 M €	+502%	1,3 M €	-9.1%	1,4 M €	+37.2%	1,1 M €	-36.1%	1,6 M €	+13.6%	1,4 M €	-9.4%	1,6 M €	+50.9%	1,1 M €	-71.2%	3,7 M €	-41.6%	6,3 M €	+33.2%	4,7 M €
Other
Workforce	68,9 ETP	+4.1%	66,2 ETP	+2.8%	64,4 ETP	-0.8%	64,9 ETP	+1.2%	64,1 ETP	-4.3%	67,0 ETP	-10.4%	74,8 ETP	-4.8%	78,6 ETP	+2.7%	76,5 ETP	+9.0%	70,2 ETP	+4.3%	67,3 ETP	+0.7%	66,8 ETP	+3.2%	64,7 ETP	-8.2%	70,5 ETP	+17.3%	60,1 ETP	+63.3%	36,8 ETP	+5.1%	35,0 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 5 active · 45 ended

Active mandates

Oscar Crasson

Director · since 13 octobre 2025

Active

Nicola Mitton

Director · since 22 mars 2024 · until 13 octobre 2025

Active

Dirk Beecker

Director · since 11 décembre 2023

Active

Edward Coombes

Director · since 11 décembre 2023

Active

David Brésart

Director · since 10 mars 2022 · until 13 octobre 2025

Active

Ended mandates

David Brésart

Director · since 21 janvier 2019 · until 21 janvier 2022

Ended

Paul Martin

Director · since 01 avril 2017

Ended

Regis Duval

Managing director · since 01 avril 2017 · until 31 octobre 2017

Ended

Regis Duval

Managing director · since 01 avril 2017

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2021
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/04/2021	01/04/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/03/2021
Length of the financial year	12 months	12 months	12 months	12 months	9 months	12 months
Filing date	16/06/2026	19/06/2025	17/06/2024	12/06/2023	13/06/2022	16/09/2021
General meeting	12/06/2026	13/06/2025	14/06/2024	09/06/2023	10/06/2022	10/09/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

39 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	12/06/2026	16/06/2026	French	PDF
Full model	31/12/2024	13/06/2025	19/06/2025	French	PDF
Full model	31/12/2023	14/06/2024	17/06/2024	French	PDF
Full model	31/12/2022	09/06/2023	12/06/2023	French	PDF
Full model	31/12/2021	10/06/2022	13/06/2022	French	PDF
Full modelCorrection	31/03/2021	10/09/2021	16/09/2021	French	PDF
Full model	31/03/2021	10/09/2021	13/09/2021	French	PDF
Full model	31/03/2020	11/09/2020	14/09/2020	French	PDF
Full model	31/03/2019	16/09/2019	17/09/2019	French	PDF
Full model	31/03/2018	14/09/2018	27/09/2018	French	PDF
Full model	31/03/2017	08/09/2017	02/10/2017	French	PDF
Full model	31/03/2016	09/09/2016	21/09/2016	French	PDF
Full modelCorrection	31/03/2015	11/09/2015	06/10/2015	French	PDF
Full model	31/03/2015	11/09/2015	21/09/2015	French	PDF
Full model	31/03/2014	12/09/2014	23/09/2014	French	PDF
Full model	31/03/2013	13/09/2013	24/09/2013	French	PDF
Full model	31/03/2012	14/09/2012	26/09/2012	French	PDF
Full model	31/03/2011	09/09/2011	12/09/2011	French	PDF
Full model	31/03/2010	09/09/2010	28/09/2010	French	PDF
Full model	31/03/2009	11/09/2009	24/09/2009	French	PDF
Full model	31/03/2008	14/10/2008	23/01/2009	French	PDF
Full model	31/12/2006	08/06/2007	02/07/2007	French	PDF
Full model	31/12/2005	31/05/2006	15/06/2006	French	PDF
Full model	31/12/2004	03/06/2005	27/06/2005	French	PDF

View all 39 filings

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 5 active · 45 ended

Active mandates

Oscar Crasson

Director · since 13 octobre 2025

Active

Nicola Mitton

Director · since 22 mars 2024 · until 13 octobre 2025

Active

Dirk Beecker

Director · since 11 décembre 2023

Active

Edward Coombes

Director · since 11 décembre 2023

Active

David Brésart

Director · since 10 mars 2022 · until 13 octobre 2025

Active

Ended mandates

David Brésart

Director · since 21 janvier 2019 · until 21 janvier 2022

Ended

Paul Martin

Director · since 01 avril 2017

Ended

Regis Duval

Managing director · since 01 avril 2017 · until 31 octobre 2017

Ended

Regis Duval

Managing director · since 01 avril 2017

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates14/01/2026
DEMISSIONS, NOMINATIONS
PDF
Mandates22/07/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates02/04/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates14/02/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates19/04/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates27/12/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates09/11/2021
DEMISSIONS, NOMINATIONS
PDF
Mandates14/10/2020
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025577,4 k €↑
2024
Annual accounts 2024444 k €↑
2023
Annual accounts 2023320,4 k €↑
2022
Annual accounts 202298,3 k €↓
2021
Annual accounts 2021131,6 k €↑
2021
Annual accounts 2021-59,3 k €↓
2019
Annual accounts 2019924,4 k €↑
2018
Annual accounts 2018691,3 k €↑
2017
Annual accounts 2017411,3 k €↓
2016
Annual accounts 2016926 k €↑
2015
Annual accounts 2015609,9 k €↓
2014
Annual accounts 20141,3 M €↑
2013
Annual accounts 2013548,4 k €↑
2012
Annual accounts 2012-629,8 k €↓
2011
Annual accounts 20112 M €↑
2009
Annual accounts 2009-436,1 k €↑
2008
Annual accounts 2008-564,7 k €
16/02/1989
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

IMMUNODIAGNOSTIC SYSTEMS

Overview

What does IMMUNODIAGNOSTIC SYSTEMS do?

Trend over 17 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline